154 related articles for article (PubMed ID: 1441762)
1. [Recent advances in neuropsychopharmacology of the central serotonin receptor].
Yamawaki S; Hayakawa H
Yakubutsu Seishin Kodo; 1992 Apr; 12(2):43-54. PubMed ID: 1441762
[TBL] [Abstract][Full Text] [Related]
2. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
Montgomery SA; Fineberg N
Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
[TBL] [Abstract][Full Text] [Related]
3. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
[TBL] [Abstract][Full Text] [Related]
4. Serotonin receptor and reuptake sites: pharmacologic significance.
Gonzalez-Heydrich J; Peroutka SJ
J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
[TBL] [Abstract][Full Text] [Related]
5. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.
Giorgetti M; Tecott LH
Eur J Pharmacol; 2004 Mar; 488(1-3):1-9. PubMed ID: 15044029
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxytryptamine in the central nervous system.
Chojnacka-Wójcik E
Pol J Pharmacol; 1995; 47(3):219-35. PubMed ID: 8714755
[TBL] [Abstract][Full Text] [Related]
7. Serotonin receptor ligands and the treatment of obesity.
Vickers SP; Dourish CT
Curr Opin Investig Drugs; 2004 Apr; 5(4):377-88. PubMed ID: 15134278
[TBL] [Abstract][Full Text] [Related]
8. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
Terry AV; Buccafusco JJ; Wilson C
Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
[TBL] [Abstract][Full Text] [Related]
9. Molecular biology of serotonin receptors.
Harrington MA; Zhong P; Garlow SJ; Ciaranello RD
J Clin Psychiatry; 1992 Oct; 53 Suppl():8-27. PubMed ID: 1331030
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.
Pandey SC; Davis JM; Pandey GN
J Psychiatry Neurosci; 1995 May; 20(3):215-25. PubMed ID: 7786883
[TBL] [Abstract][Full Text] [Related]
11. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
[TBL] [Abstract][Full Text] [Related]
12. [The 5-HT1A receptors: from molecular biology to neuropsychiatric symptoms].
Navinés R; Gómez E; Gastó C
Actas Esp Psiquiatr; 2003; 31(5):272-83. PubMed ID: 14557952
[TBL] [Abstract][Full Text] [Related]
13. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
Moulignier A
Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
[TBL] [Abstract][Full Text] [Related]
14. Use of serotonergic agents in the clinical assessment of central serotonin function.
Murphy DL; Mueller EA; Garrick NA; Aulakh CS
J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
[TBL] [Abstract][Full Text] [Related]
15. [The serotonin hypothesis of depression].
Lesch KP; Beckmann H
Fortschr Neurol Psychiatr; 1990 Nov; 58(11):427-38. PubMed ID: 2177721
[TBL] [Abstract][Full Text] [Related]
16. Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
Burns CM; Chu H; Rueter SM; Hutchinson LK; Canton H; Sanders-Bush E; Emeson RB
Nature; 1997 May; 387(6630):303-8. PubMed ID: 9153397
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Kuroki T; Nagao N; Nakahara T
Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
Plassat JL; Amlaiky N; Hen R
Mol Pharmacol; 1993 Aug; 44(2):229-36. PubMed ID: 8394987
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine receptors.
Zifa E; Fillion G
Pharmacol Rev; 1992 Sep; 44(3):401-58. PubMed ID: 1359584
[No Abstract] [Full Text] [Related]
20. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems.
Murphy DL
Neuropsychopharmacology; 1990; 3(5-6):457-71. PubMed ID: 2078279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
